70 related articles for article (PubMed ID: 24152817)
1. Malignant astrocytoma in elderly patients: where do we stand?
Tabatabai G; Stupp R; Wick W; Weller M
Curr Opin Neurol; 2013 Dec; 26(6):693-700. PubMed ID: 24152817
[TBL] [Abstract][Full Text] [Related]
2. O6-methylguanine-DNA methyltransferase methylation and TP53 mutation in malignant astrocytomas and their relationships with clinical course.
Watanabe T; Katayama Y; Komine C; Yoshino A; Ogino A; Ohta T; Fukushima T
Int J Cancer; 2005 Feb; 113(4):581-7. PubMed ID: 15455376
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of glioblastoma multiforme in elderly patients: treatments, O-6-methylguanine-DNA methyltransferase (MGMT) methylation status and survival.
Abhinav K; Aquilina K; Gbejuade H; La M; Hopkins K; Iyer V
Clin Neurol Neurosurg; 2013 Aug; 115(8):1375-8. PubMed ID: 23333005
[TBL] [Abstract][Full Text] [Related]
4. A hypermethylated phenotype is a better predictor of survival than MGMT methylation in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951.
van den Bent MJ; Gravendeel LA; Gorlia T; Kros JM; Lapre L; Wesseling P; Teepen JL; Idbaih A; Sanson M; Smitt PA; French PJ
Clin Cancer Res; 2011 Nov; 17(22):7148-55. PubMed ID: 21914791
[TBL] [Abstract][Full Text] [Related]
5. O6 -methylguanine DNA methyltransferase gene promoter methylation in high-grade gliomas: a review of current status.
Suri V; Jha P; Sharma MC; Sarkar C
Neurol India; 2011; 59(2):229-35. PubMed ID: 21483124
[TBL] [Abstract][Full Text] [Related]
6. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
7. A huge intraventricular congenital anaplastic astrocytoma: case report with histopathological and genetic consideration.
Yamashita S; Ryu S; Miyata S; Uchinokura S; Yokogami K; Uehara H; Moriguchi S; Iwakiri T; Marutsuka K; Ikenoue M; Sawa D; Yamada N; Kodama Y; Takeshima H
Brain Tumor Pathol; 2012 Apr; 29(2):107-12. PubMed ID: 22139530
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic efficacy and prognostic factors in diffuse astrocytomas].
Watanabe T; Komine C; Yokoyama T; Yoshino A; Katayama Y
No Shinkei Geka; 2003 Jul; 31(7):767-73. PubMed ID: 12884791
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas.
Brell M; Tortosa A; Verger E; Gil JM; Viñolas N; Villá S; Acebes JJ; Caral L; Pujol T; Ferrer I; Ribalta T; Graus F
Clin Cancer Res; 2005 Jul; 11(14):5167-74. PubMed ID: 16033832
[TBL] [Abstract][Full Text] [Related]
10. Extent and patterns of MGMT promoter methylation in glioblastoma- and respective glioblastoma-derived spheres.
Sciuscio D; Diserens AC; van Dommelen K; Martinet D; Jones G; Janzer RC; Pollo C; Hamou MF; Kaina B; Stupp R; Levivier M; Hegi ME
Clin Cancer Res; 2011 Jan; 17(2):255-66. PubMed ID: 21097691
[TBL] [Abstract][Full Text] [Related]
11. Management of elderly patients with glioblastoma-multiforme-a systematic review.
Asmaa A; Dixit S; Rowland-Hill C; Achawal S; Rajaraman C; O'Reilly G; Highley R; Hussain M; Baker L; Gill L; Morris H; Hingorani M
Br J Radiol; 2018 Jul; 91(1088):20170271. PubMed ID: 29376741
[TBL] [Abstract][Full Text] [Related]
12. O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort.
Pollack IF; Hamilton RL; Sobol RW; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL
J Clin Oncol; 2006 Jul; 24(21):3431-7. PubMed ID: 16849758
[TBL] [Abstract][Full Text] [Related]
13. Recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2) immunotherapy with ranimustine chemotherapy and concurrent radiation therapy for malignant astrocytomas.
Fukushima T; Yamamoto M; Oshiro S; Tsugu H; Hirakawa K; Soma G
Anticancer Res; 2003; 23(6a):4473-81. PubMed ID: 14666736
[TBL] [Abstract][Full Text] [Related]
14. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
Koga Y; Kitajima Y; Miyoshi A; Sato K; Kitahara K; Soejima H; Miyazaki K
Ann Surg Oncol; 2005 May; 12(5):354-63. PubMed ID: 15915369
[TBL] [Abstract][Full Text] [Related]
15. Glioblastoma Treatment in the Elderly.
Okada M; Miyake K; Tamiya T
Neurol Med Chir (Tokyo); 2017 Dec; 57(12):667-676. PubMed ID: 29081442
[TBL] [Abstract][Full Text] [Related]
16. Anaplastic Astrocytoma: State of the art and future directions.
Caccese M; Padovan M; D'Avella D; Chioffi F; Gardiman MP; Berti F; Busato F; Bellu L; Bergo E; Zoccarato M; Fassan M; Zagonel V; Lombardi G
Crit Rev Oncol Hematol; 2020 Sep; 153():103062. PubMed ID: 32717623
[TBL] [Abstract][Full Text] [Related]
17. Glioblastoma in Elderly Patients: Current Management and Future Perspectives.
Minniti G; Lombardi G; Paolini S
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30857221
[TBL] [Abstract][Full Text] [Related]
18. [Clinical trial updates for malignant brain tumors].
Wakabayashi T
Rinsho Shinkeigaku; 2011 Nov; 51(11):853-6. PubMed ID: 22277391
[TBL] [Abstract][Full Text] [Related]
19. Being old is no fun: treatment of glioblastoma multiforme in the elderly.
Chiocca EA
J Neurosurg; 2008 Apr; 108(4):639-40. PubMed ID: 18377239
[No Abstract] [Full Text] [Related]
20. Report of a workshop sponsored by the European Organisation for Research and Treatment of Cancer (EORTC) on the treatment of primary malignant brain tumours.
Hildebrand J; Thomas DG
J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):182-3. PubMed ID: 1850453
[No Abstract] [Full Text] [Related]
[Next] [New Search]
